- Home
- ARCT vs DHC Comparison
ARCT vs DHC Comparison
Compare ARCT & DHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- DHC
- Stock Information
- Founded
- ARCT 2013
- DHC 1998
- Country
- ARCT United States
- DHC United States
- Employees
- ARCT N/A
- DHC N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- DHC Real Estate Investment Trusts
- Sector
- ARCT Health Care
- DHC Real Estate
- Exchange
- ARCT Nasdaq
- DHC Nasdaq
- Market Cap
- ARCT 487.0M
- DHC 629.7M
- IPO Year
- ARCT N/A
- DHC N/A
- Fundamental
- Price
- ARCT $15.88
- DHC $2.63
- Analyst Decision
- ARCT Strong Buy
- DHC Hold
- Analyst Count
- ARCT 8
- DHC 3
- Target Price
- ARCT $61.00
- DHC $4.50
- AVG Volume (30 Days)
- ARCT 405.9K
- DHC 989.6K
- Earning Date
- ARCT 03-06-2025
- DHC 02-25-2025
- Dividend Yield
- ARCT N/A
- DHC 1.54%
- EPS Growth
- ARCT N/A
- DHC N/A
- EPS
- ARCT N/A
- DHC N/A
- Revenue
- ARCT $160,399,000.00
- DHC $1,477,343,000.00
- Revenue This Year
- ARCT $7.33
- DHC N/A
- Revenue Next Year
- ARCT $4.71
- DHC $4.46
- P/E Ratio
- ARCT N/A
- DHC N/A
- Revenue Growth
- ARCT N/A
- DHC 6.62
- 52 Week Low
- ARCT $14.30
- DHC $2.01
- 52 Week High
- ARCT $45.00
- DHC $4.24
- Technical
- Relative Strength Index (RSI)
- ARCT 41.74
- DHC 67.74
- Support Level
- ARCT $16.03
- DHC $2.39
- Resistance Level
- ARCT $17.95
- DHC $2.50
- Average True Range (ATR)
- ARCT 1.29
- DHC 0.13
- MACD
- ARCT -0.07
- DHC 0.07
- Stochastic Oscillator
- ARCT 10.29
- DHC 93.85
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.
About DHC Diversified Healthcare Trust of Beneficial Interest
Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. It operates through two segments: Office Portfolio and SHOP. The office portfolio includes medical office properties leased to medical-related businesses and life sciences properties. The SHOP segment runs communities that offer multiple types of residential care, ranging from independent living to nursing services. DHT operates across the United States and the majority of its revenue derives from rents and medical programs.